207 related articles for article (PubMed ID: 36896570)
41. Alpha1-antitrypsin deficiency: New therapies on the horizon.
Remih K; Amzou S; Strnad P
Curr Opin Pharmacol; 2021 Aug; 59():149-156. PubMed ID: 34256305
[TBL] [Abstract][Full Text] [Related]
42. Current status of gene therapy for α-1 antitrypsin deficiency.
Loring HS; Flotte TR
Expert Opin Biol Ther; 2015 Mar; 15(3):329-36. PubMed ID: 25363251
[TBL] [Abstract][Full Text] [Related]
43. Practical dietary advices for subjects with alpha-1 antitrypsin deficiency.
Rondanelli M; Gasparri C; Razza C; Ferraris C; Perna S; Ferrarotti I; Corsico AG
Biomed Pharmacother; 2023 Jul; 163():114753. PubMed ID: 37119738
[TBL] [Abstract][Full Text] [Related]
44. Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.
Fromme M; Schneider CV; Trautwein C; Brunetti-Pierri N; Strnad P
J Hepatol; 2022 Apr; 76(4):946-958. PubMed ID: 34848258
[TBL] [Abstract][Full Text] [Related]
45. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
Barjaktarevic I; Miravitlles M
BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
[TBL] [Abstract][Full Text] [Related]
46. Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.
Kueppers F; Andrake MD; Xu Q; Dunbrack RL; Kim J; Sanders CL
BMC Med Genet; 2019 Jul; 20(1):125. PubMed ID: 31307431
[TBL] [Abstract][Full Text] [Related]
47. Alpha1-antitrypsin deficiency: what's new after European Respiratory Society Statement.
Patrucco F; Venezia L; Gavelli F; Pellicano R; Solidoro P
Panminerva Med; 2018 Sep; 60(3):101-108. PubMed ID: 29696962
[TBL] [Abstract][Full Text] [Related]
48. Randomized, Placebo-Controlled Trials in Alpha-1 Antitrypsin Deficiency.
Sandhaus RA
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S370-3. PubMed ID: 27564674
[TBL] [Abstract][Full Text] [Related]
49. The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis.
Veith M; Tüffers J; Peychev E; Klemmer A; Kotke V; Janciauskiene S; Wilhelm S; Bals R; Koczulla AR; Vogelmeier CF; Greulich T
Int J Chron Obstruct Pulmon Dis; 2020; 15():2827-2836. PubMed ID: 33192056
[TBL] [Abstract][Full Text] [Related]
50. Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil.
Jardim JR; Casas-Maldonado F; Fernandes FLA; Castellano MVCO; Torres-Durán M; Miravitlles M
J Bras Pneumol; 2021; 47(3):e20200380. PubMed ID: 34076174
[TBL] [Abstract][Full Text] [Related]
51. Cardiovascular risk in patients with alpha-1-antitrypsin deficiency.
Fähndrich S; Biertz F; Karch A; Kleibrink B; Koch A; Teschler H; Welte T; Kauczor HU; Janciauskiene S; Jörres RA; Greulich T; Vogelmeier CF; Bals R;
Respir Res; 2017 Sep; 18(1):171. PubMed ID: 28915894
[TBL] [Abstract][Full Text] [Related]
52. Alpha-1 antitrypsin augmentation therapy.
Wewers MD; Crystal RG
COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
[TBL] [Abstract][Full Text] [Related]
53. α
Bazzan E; Tinè M; Biondini D; Benetti R; Baraldo S; Turato G; Fagiuoli S; Sonzogni A; Rigobello C; Rea F; Calabrese F; Foschino-Barbaro MP; Miranda E; Lomas DA; Saetta M; Cosio MG
Chest; 2018 Sep; 154(3):607-616. PubMed ID: 29763589
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype.
Bjursell M; Porritt MJ; Ericson E; Taheri-Ghahfarokhi A; Clausen M; Magnusson L; Admyre T; Nitsch R; Mayr L; Aasehaug L; Seeliger F; Maresca M; Bohlooly-Y M; Wiseman J
EBioMedicine; 2018 Mar; 29():104-111. PubMed ID: 29500128
[TBL] [Abstract][Full Text] [Related]
55. Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.
Turner AM
BioDrugs; 2013 Dec; 27(6):547-58. PubMed ID: 23771682
[TBL] [Abstract][Full Text] [Related]
56. Population genetic screening for alpha1-antitrypsin deficiency in a high-prevalence area.
Corda L; Medicina D; La Piana GE; Bertella E; Moretti G; Bianchi L; Pinelli V; Savoldi G; Baiardi P; Facchetti F; Gatta N; Annesi-Maesano I; Balbi B
Respiration; 2011; 82(5):418-25. PubMed ID: 21474916
[TBL] [Abstract][Full Text] [Related]
57. Alpha-1-antitrypsin deficiency-related panniculitis: two cases with diverse clinical courses.
Storan ER; O' Gorman SM; Hawkins P; Aalto L; Murphy A; Markham T
Clin Exp Dermatol; 2017 Jul; 42(5):520-522. PubMed ID: 28512995
[TBL] [Abstract][Full Text] [Related]
58. Alpha-1 antitrypsin deficiency: outstanding questions and future directions.
Torres-Durán M; Lopez-Campos JL; Barrecheguren M; Miravitlles M; Martinez-Delgado B; Castillo S; Escribano A; Baloira A; Navarro-Garcia MM; Pellicer D; Bañuls L; Magallón M; Casas F; Dasí F
Orphanet J Rare Dis; 2018 Jul; 13(1):114. PubMed ID: 29996870
[TBL] [Abstract][Full Text] [Related]
59. [Molecular diagnostics of alpha-1-antitrypsin deficiency in clinical practice].
Struniawski R; Szpechciński A; Chorostowska-Wynimko J
Pneumonol Alergol Pol; 2008; 76(4):253-64. PubMed ID: 18785130
[TBL] [Abstract][Full Text] [Related]
60. PredictAAT: Accounting for Inflammation in the Diagnosis of Alpha 1 Antitrypsin Deficiency.
Kueppers F
COPD; 2020 Dec; 17(6):619-622. PubMed ID: 32862719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
